Verrica Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.73%37.160.9%$1870.41m
ABBVAbbVie, Inc. 0.66%104.891.9%$1090.45m
JNJJohnson & Johnson 0.27%144.060.7%$1080.11m
BMYBristol-Myers Squibb Co. 0.34%63.061.0%$714.76m
MRKMerck & Co., Inc. -0.60%79.580.7%$689.98m
LLYEli Lilly & Co. 1.17%146.451.1%$687.19m
AZNAstraZeneca Plc -0.76%52.201.2%$286.12m
GSKGlaxoSmithKline Plc -0.44%37.070.2%$233.58m
NVSNovartis AG 0.26%89.410.2%$179.90m
NVONovo Nordisk A/S 1.89%67.390.1%$96.25m
RGENRepligen Corp. 2.27%185.567.1%$94.83m
SNYSanofi 1.57%50.990.2%$76.44m
ARCTArcturus Therapeutics Holdings, Inc. 24.00%75.180.0%$71.48m
RPRXRoyalty Pharma Plc 2.04%41.810.2%$67.68m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.65%91.100.0%$67.66m

Company Profile

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.